The mission of the Gilead Sciences Research Scholars Program in Hematology/Oncology is to support innovative research that will advance knowledge in the field of hematology/oncology and provide support for research career development.
To that end, grants of up to $130,000 over two years will be awarded to junior faculty researchers for innovative translational research projects in hematology/oncology (with a focus on hematologic malignancies) that can be either based around a clinical trial with strong correlative science or laboratory investigation.
To be eligible, applicants must hold an MD, DO, PhD, or equivalent degree at time of award; be within five years of his/her initial faculty appointment in association with an academic research institution in the United States or Canada at the time of application; have a strong career interest in hematology/oncology, with a focus on hematologic malignancies; have a research mentor with extensive experience in the field of hematology/oncology, with a focus on hematologic malignancies; be able to devote at least 50 percent of his/her professional time to research (versus administrative, patient care, or teaching responsibilities); and be able to complete the proposed research within the two-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects.
In addition, applicants must be a citizen or permanent resident of the United States or Canada or hold a temporary non-immigrant visa.
For complete program guidelines, information about scholars from previous years, and application instructions, see the Gilead Sciences website.